πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10301323

Histone deacetylase inhibitors

BIOMARIN PHARMACEUTICAL INC. Β· Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10301317

Inhibitors of ERK and methods of use

Kura Oncology, Inc. Β· Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10300107

Compositions and methods for CaMKII inhibitors and uses thereof

The Regents of the University of Colorado, a Body Corporate Β· Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10300073

Use of CDK9 and BRD4 inhibitors to inhibit inflammation

The Regents of the University of California Β· Granted Tue May 28 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10293022

Peptide inhibitors of serotonin 5-HT2C receptor:PTEN interaction

THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYTEM Β· Granted Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10292979

Methods of treating cancer patients with farnesyltransferase inhibitors

Kura Oncology, Inc. Β· Granted Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10287295

TGF-Ξ² inhibitors

Rigel Pharmaceuticals, Inc. Β· Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10287279

Inhibitors of human 12/15-lipoxygenase

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 14 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10280422

MiR-92 inhibitors and uses thereof

MIRAGEN THERAPEUTICS, INC. Β· Granted Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10280171

Heterocyclic inhibitors of PTPN11

The Board of Regents of the University of Texas System Β· Granted Tue May 07 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 02 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10273233

Inhibitors of influenza viruses replication

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10273218

BCL-3 inhibitors

University College Cardiff Consultants Limited Β· Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10272132

Peptide and peptidomimetic inhibitors

RA PHARMACEUTICALS, INC. Β· Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10272084

Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripher

The Board of Regents of the University of Texas System Β· Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10272074

Inhibitors of glucocorticoid receptor translocation

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Β· Granted Tue Apr 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10266549

ULK1 inhibitors and methods using same

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE Β· Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10266542

EZH2 inhibitors

Mirati Therapeutics, Inc. Β· Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10266539

Polymorph of Syk inhibitors

GILEAD CONNECTICUT, INC. Β· Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10266488

4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide derivatives as potent and selective

THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES Β· Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10265313

Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 23 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10258627

DNA-PK inhibitors

Vertex Pharmaceuticals Incorporated Β· Granted Tue Apr 16 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 11 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10253044

9H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain inhibitors

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10253039

Inhibitors of bacterial DNA gyrase with efficacy against gram-negative bacteria

The Regents of the University of California Β· Granted Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10246463

Hypoxia-inducible factor 1 (HIF-1) inhibitors

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 02 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted